In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response Journal Article


Authors: Sahu, A.; Kose, K.; Kraehenbuehl, L.; Byers, C.; Holland, A.; Tembo, T.; Santella, A.; Alfonso, A.; Li, M.; Cordova, M.; Gill, M.; Fox, C.; Gonzalez, S.; Kumar, P.; Wang, A. W.; Kurtansky, N.; Chandrani, P.; Yin, S.; Mehta, P.; Navarrete-Dechent, C.; Peterson, G.; King, K.; Dusza, S.; Yang, N.; Liu, S.; Phillips, W.; Guitera, P.; Rossi, A.; Halpern, A.; Deng, L.; Pulitzer, M.; Marghoob, A.; Chen, C. S. J.; Merghoub, T.; Rajadhyaksha, M.
Article Title: In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response
Abstract: Response to immunotherapies can be variable and unpredictable. Pathology-based phenotyping of tumors into ‘hot’ and ‘cold’ is static, relying solely on T-cell infiltration in single-time single-site biopsies, resulting in suboptimal treatment response prediction. Dynamic vascular events (tumor angiogenesis, leukocyte trafficking) within tumor immune microenvironment (TiME) also influence anti-tumor immunity and treatment response. Here, we report dynamic cellular-level TiME phenotyping in vivo that combines inflammation profiles with vascular features through non-invasive reflectance confocal microscopic imaging. In skin cancer patients, we demonstrate three main TiME phenotypes that correlate with gene and protein expression, and response to toll-like receptor agonist immune-therapy. Notably, phenotypes with high inflammation associate with immunostimulatory signatures and those with high vasculature with angiogenic and endothelial anergy signatures. Moreover, phenotypes with high inflammation and low vasculature demonstrate the best treatment response. This non-invasive in vivo phenotyping approach integrating dynamic vasculature with inflammation serves as a reliable predictor of response to topical immune-therapy in patients. © 2022, The Author(s).
Keywords: phenotype; inflammation; protein; immunotherapy; immunity; immunologic factors; immunologic factor; tumor microenvironment; humans; human
Journal Title: Nature Communications
Volume: 13
ISSN: 2041-1723
Publisher: Nature Publishing Group  
Date Published: 2022-09-09
Start Page: 5312
Language: English
DOI: 10.1038/s41467-022-32738-7
PUBMED: 36085288
PROVIDER: scopus
PMCID: PMC9463451
DOI/URL:
Notes: Article -- Export Date: 3 October 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Allan C Halpern
    396 Halpern
  2. Taha Merghoub
    364 Merghoub
  3. Melissa P Pulitzer
    203 Pulitzer
  4. Stephen Dusza
    288 Dusza
  5. Liang Deng
    82 Deng
  6. Chih-Shan Jason Chen
    55 Chen
  7. Ashfaq A Marghoob
    534 Marghoob
  8. Anthony Rossi
    233 Rossi
  9. Kivanc Kose
    81 Kose
  10. Miguel A Cordova
    88 Cordova
  11. Aditi Kamlesh Sahu
    30 Sahu
  12. Ning Yang
    25 Yang
  13. Aliya Rose Ming Holland
    18 Holland
  14. Kimeil Jehlia King
    4 King
  15. Shuaitong Liu
    10 Liu
  16. Paras Mehta
    14 Mehta
  17. Teguru Cosmas Tembo
    2 Tembo
  18. Madison Jaimee Li
    2 Li
  19. Shen Yin
    11 Yin